ArticleNature cancer2022

Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer.

Nancy Gavert et al.PubMed ↗Publisher ↗

No numbers read from the abstract.